These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1649271)

  • 1. Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
    Labrousse F; Daumas-Duport C; Batorski L; Hoshino T
    J Neurosurg; 1991 Aug; 75(2):202-5. PubMed ID: 1649271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
    Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
    J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
    Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
    Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading of astrocytomas. A simple and reproducible method.
    Daumas-Duport C; Scheithauer B; O'Fallon J; Kelly P
    Cancer; 1988 Nov; 62(10):2152-65. PubMed ID: 3179928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of S-phase cells in human gliomas].
    Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
    No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of the proliferative potential of low-grade astrocytomas.
    Hoshino T; Rodriguez LA; Cho KG; Lee KS; Wilson CB; Edwards MS; Levin VA; Davis RL
    J Neurosurg; 1988 Dec; 69(6):839-42. PubMed ID: 3193189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of the bromodeoxyuridine labeling index of astrocytic tumors between primary and recurrent lesions.
    Tamura M; Ono N; Zama A; Kurihara H
    Noshuyo Byori; 1994; 11(2):173-6. PubMed ID: 7894621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].
    Takekawa Y; Sawada T; Sakurai I
    Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative potential and prognostic evaluation of low-grade astrocytomas.
    Ito S; Chandler KL; Prados MD; Lamborn K; Wynne J; Malec MK; Wilson CB; Davis RL; Hoshino T
    J Neurooncol; 1994; 19(1):1-9. PubMed ID: 7815099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
    Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
    Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres.
    McDermott MW; Krouwer HG; Asai A; Ito S; Hoshino T; Prados MD
    Can J Neurol Sci; 1992 Feb; 19(1):34-9. PubMed ID: 1562905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the proliferative potential of human gliomas.
    Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
    J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions.
    Khalid H; Tsutsumi K; Yamashita H; Kishikawa M; Yasunaga A; Shibata S
    Cell Mol Neurobiol; 1995 Apr; 15(2):257-68. PubMed ID: 8590455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling.
    Ito S; Hoshino T; Shibuya M; Prados MD; Edwards MS; Davis RL
    Neurosurgery; 1992 Sep; 31(3):413-8; discussion 419. PubMed ID: 1407423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.